Vascular allografts market seen growing to $2.58 billion by 2030

The vascular allografts market reached $1.84 billion in 2025 and is projected to hit $2.58 billion by 2030, driven by rising cardiovascular disease, surgical demand and advances in graft materials. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The vascular allografts market is tied to rising cardiovascular disease, which is increasing demand for vessel replacement and bypass options. - Faster growth in graft preservation, minimally invasive procedures and regenerative medicine could widen treatment options and improve surgical outcomes. - The market’s projected climb to $2.58 billion by 2030 signals continued spending on vascular surgery products and hospital capabilities.

What happened: - The Business Research Company published a 2026 market outlook for vascular allografts. - The report estimated the market at $1.84 billion in 2025. - The market is projected to reach $1.97 billion in 2026, implying 7.1% annual growth. - The report forecasts the market will rise to $2.58 billion by 2030, at a 7.0% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region over the next few years.

The details: - Vascular allografts are blood vessels taken from human donors and transplanted into patients who need replacement or bypass of damaged or diseased vessels. - These grafts are used when a patient’s own vessels are not suitable for surgery. - The grafts support bypass operations and vascular reconstruction procedures. - The market has been shaped by limited donor graft supply, continued use of conventional surgery, more cardiovascular disease cases and expanding hospital infrastructure. - The report also points to early adoption of cortical and cancellous graft materials. - Growth drivers through 2030 include advances in graft preservation and processing, more minimally invasive vascular procedures, more transplant surgeries, wider use of composite and polymer-based grafts, and more regenerative medicine research. - Emerging trends include stronger demand in cardiovascular interventions, greater use of cortical and cancellous allografts, more fresh frozen and freeze-dried graft types, growth in peripheral vascular and transplant surgeries, and innovation in biological and composite materials. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The 2026 report edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The report offers a free sample: Download a free sample - The full report is available here: View the full vascular allografts market report

Between the lines: - The forecast suggests demand is being driven less by one single technology shift and more by a mix of disease burden, surgical need and materials innovation. - North America’s lead reflects mature healthcare systems, while Asia-Pacific’s growth points to rising access and demand in emerging markets. - The mention of fresh frozen, freeze-dried and composite grafts suggests the category is broadening beyond traditional graft formats.

What's next: - The market is expected to keep expanding through 2030 if cardiovascular disease rates and surgical volumes continue rising. - Investment in regenerative medicine, preservation methods and graft materials is likely to shape product development and competitive positioning. - Regional growth will likely stay uneven, with North America strong and Asia-Pacific gaining share.